FIELD: medicine.
SUBSTANCE: invention is intended for treatment of irritable bowel syndrome with constipation (IBS-C) associated with the bacterial overgrowth syndrome (BOGS). Mebeverine, 0.2 g, 2 times a day in combination with 30 ml of lactulose per day for 3 months are prescribed. Three courses of sequential therapy carried out without interruption and consisting of 0.4 g of rifaximin two times a day for 6 days, then 0.25 g of enterol 2 times a day for 10 days, then bifiform 1 capsule 2 times per day for 15 days, are prescribed simultaneously.
EFFECT: method enables higher clinical effectiveness.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF EXCESS BACTERIAL GROWTH IN SMALL INTESTINE IN PATIENTS WITH TYPE 2 DIABETES IN COMBINATION WITH GASTRODUODENAL HELICOBACTERIOSIS | 2017 |
|
RU2674447C1 |
| METHOD FOR TREATMENT OF IRRITABLE BODY SYNDROME | 2017 |
|
RU2661624C1 |
| METHOD OF INVESTIGATION OF THE REASONS OF REFRACTIVE CONJUGATION IN PATIENTS WITH SYNDROME OF IRRITATED INTELLIGENCE | 2015 |
|
RU2620001C1 |
| METHODS FOR TREATING IRRITABLE BOWEL SYNDROME (IBS) | 2010 |
|
RU2582940C2 |
| METHOD FOR CORRECTION OF PSYCHOSOMATIC DISEASES IN PATIENTS WITH IRRITATED BOWEL SYNDROME | 2017 |
|
RU2637628C1 |
| METHOD OF TREATING INTESTINAL DISEASES | 2009 |
|
RU2519649C2 |
| ORAL RIFAMYCIN SV COMPOSITIONS | 2018 |
|
RU2793319C2 |
| METHOD OF OBTAINING PERSONIFIED AUTOPROBIOTIC PRODUCT AND METHOD OF TREATING SYNDROME OF IRRITABLE BOWL WITH THEREOF APPLICATION | 2013 |
|
RU2546253C2 |
| METHOD OF PREVENTION POST-INFECTIOUS IRRITABLE BOWEL SYNDROME | 2014 |
|
RU2553372C1 |
| METHOD OF TREATING PATIENTS WITH INTESTINAL DISBACTERIOSIS | 2014 |
|
RU2571495C1 |
